The Technology Tree of Xueba

Wang Xiaoxiao handed the brief experimental data to Zhou Yu and said with a smile: "General Manager Zhou, you can understand me after reading the experimental data."

Zhou Yu immediately checked Wang Xiaoxiao's experimental data.

He saw that the animal experiment was the African green long-tailed monkey. The most important experimental data was the HIV concentration and activity collected in the previous week.

After a simple summary analysis, you can easily draw conclusions.

HIV is closely related to the human herpesvirus-6 virus, and Wang Xiaoxiao has cracked the codes associated with these two viruses.

Through the comparative experiment of pheromone and interferon, the way that the pheromone released by human herpesvirus-6 virus combined with HIV was researched, and how the interferon released by human herpesvirus-6 virus interfered the immune system.

After Wang Xiaoxiao learned of these biological codes, he artificially synthesized inducins to drive the human immune system to actively kill HIV.

This is as if in a fog-filled battlefield, radar is turned on for the immune system side so that they can accurately locate the HIV virus.

Through animal experiments, it has been proved that inducins can definitely guide the immune system to trap most HIV.

After reading the experimental data of Wang Xiaoxiao, Zhou Yu said with surprise: "Director Wang, I didn't expect that you could achieve this level, and found the biological code of HIV.

Since inducins can guide the immune system to attack HIV, why do you deny that it can cure AIDS. "

Wang Xiaoxiao saw that Zhou Yu had understood his experimental data, so he did not have to bother to explain the experimental data to Zhou Yu.

He directly stated the specific reasons, saying: "General Manager Zhou, we have not developed drugs that target and kill HIV. We just target HIV and induce the human immune system to kill HIV.

But HIV is a very cunning virus, which has been observed in our laboratory for a long time.

HIV parasites into lymphatic T cells, and they don't all immediately start a value-added procedure.

A very small part of HIV sleeps in the lymph T cells of the immune glands such as the thymus and lymph nodes, and also makes this lymph T cells ineffective.

The sleeping HIV cannot receive the biological signal from human herpesvirus-6 virus, and our inducer adopts the human herpesvirus-6 virus biological signal-related pathway, so it cannot reach the lymphatic T of this HIV parasite. Inside the cell. "

Zhou Yu listened carefully to Wang Xiaoxiao's words. He found that he was blindly optimistic. The HIV disease, which has plagued humans for decades, could not be solved so easily.

"Director Wang, what effect does this inducer you have studied, since you can stop the experiment, you should have reached the goal set by the experiment." Zhou Yu asked expectantly.

At the beginning of the establishment of the HIV project, the biggest goal was to completely cure AIDS, but no one took this goal as a real goal, but just regarded it as an ideal.

The initial goal of the laboratory was to find an AIDS treatment with low side effects, low virus resistance, and long-term use.

Wang Xiaoxiao said with a smile: "We spent 3.8 billion yuan on such a long time of research. If no more results are achieved, we will be sorry for ourselves."

He reported in detail to Zhou Yu how the inducer controls AIDS.

Inducin guides the body's immune system and can kill HIV in human blood and most body fluids. Only a small amount of HIV remains in the lymph fluid. They are inside the glands of the thymus and lymph nodes, not in the lymphatic vessels surrounding the body. .

Inducin is a peptide that can exist in human body fluids for up to a year.

As long as the AIDS patient has not died, after using the inducer, the body's residual immune system can respond quickly, gradually killing most of the HIV in the human body and gradually returning to normal.

After HIV carriers use inducers, HIV is not present in blood and other body fluids, so they will not be transmitted through blood, sex, mother-to-child transmission channels.

This is equivalent to cutting off the transmission of AIDS, which has changed from a high-risk infectious disease to a disease of the patient itself.

Its social harm is greatly reduced. If controlled properly, like rabies is eliminated in some countries, AIDS can also be eliminated in some areas.

In summary, what Wang Xiaoxiao means is that AIDS can be controlled but not cured.

Zhou Yu laughed twice, stood up and patted Wang Xiaoxiao's shoulder, and said happily, "Director Wang, you have done a great job. As long as you persist in promoting inducers, we will eliminate HIV sooner or later.

This technology has been developed to such an extent that it can be officially ended. How about the yield of inducin? Is it expensive? "

"Total Zhou, the production cost of inducin per kilogram is about 100 million yuan, and the production rate is very slow. Our laboratory can only produce about one gram per day.

If a pharmaceutical factory is built for industrial production, its output should increase significantly.

This project can only be said to be half successful, and we do not yet know what chain reaction will occur when inducin is injected into the human body.

If its side effects are very serious, then this medicine is not as effective as we think.

We also don't know whether the inducer in the human body can achieve the effect shown in African green long-tailed monkeys.

To know this data, we must conduct human experiments.

If you want to start human experiments, you must apply for it from relevant departments such as the Health and Health Commission. Our animal experiment procedures must be exposed, and the composition of inducible polymorphisms needs to be disclosed.

Mr. Zhou, if we want to hold this technology for a long time, we can choose some countries for human experiments, such as India, and they have a very large loophole in the audit of pharmaceutical companies.

Major international pharmaceutical companies have laboratories in India to facilitate confidential and convenient human experiments. "

After answering Zhou Yu's question, Wang Xiaoxiao also raised the question in his own mind.

Zhou Yu chuckled softly: "We have no shortage of money for Spark Technology. Of course, no one is too small for the money we earn.

But I ca n’t make money with ambiguity. Besides setting up an AIDS project, UU reads www. uukanshu.com's original intention is to completely cure AIDS, not to make money.

Otherwise, why should I choose the difficult bone of AIDS, drugs such as broad-spectrum antibiotics, which are not better than AIDS drugs, and the application market is huge.

You leave the matter to Huang Ke, and after the inducin-related patent comes down, let him apply for physical experiments in accordance with the normal process. "

When Wang Xiaoxiao heard what Zhou Yu said, he was full of respect. He has been exuberant in the past few years. He has seen many unscrupulous capitalists. Capitalists like Zhou Yu are really rare.

Some well-known pharmaceutical companies in the world clearly have better medicaments. They choose medicaments that have poorer treatment effects and require long-term administration.

It is to find ways to make high profits, such as the proportion of US medicine in GDP as high as 18%.

"General Manager Zhou, I immediately sorted out the experimental data and sent the relevant data to Huang Ke. After the AIDS project ended and the technology was officially transferred to the relevant company, I started a new project." Wang Xiaoxiao said neatly.

The company Spark Technology is worth his life.